Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.5242
Schlusskurs vom Vortag:
$0.5242
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$56.66M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.35M
KGV:
0.00
EPS:
-0.4554
Netto-Cashflow:
$-5.51M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$3.9099
Klotho Neurosciences Inc Stock (KLTO) Company Profile
Firmenname
Klotho Neurosciences Inc
Sektor
Branche
Telefon
(833) 931-6330
Adresse
13576 WALNUT STREET, SUITE A, OMAHA
Compare KLTO vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KLTO
Klotho Neurosciences Inc
|
0.00 | 56.66M | 0 | -11.35M | -5.51M | -0.4554 |
VRTX
Vertex Pharmaceuticals Inc
|
435.65 | 112.35B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
746.00 | 79.71B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
828.35 | 52.29B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
320.13 | 44.48B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
320.70 | 35.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Klotho Neurosciences Inc Aktie (KLTO) Neueste Nachrichten
Movement Recap: Is Klotho Neurosciences Inc forming a breakout pattern2026 Fed Impact & Precise Entry and Exit Recommendations - baoquankhu1.vn
Can Klotho Neurosciences Inc grow without external fundingTrade Entry Report & Real-Time Volume Triggers - baoquankhu1.vn
EV Market: What are Klotho Neurosciences Inc Equity Warrants growth levers2026 Closing Moves & Safe Entry Momentum Tips - baoquankhu1.vn
Trend Review: Is Klotho Neurosciences Inc Equity Warrant part of any major index2026 Big Picture & Real-Time Buy Zone Alerts - baoquankhu1.vn
KLTO SEC FilingsKlotho Neurosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
GREENLAND MINES APPOINTS DR. JAKOB KLØVE KEIDING AS CHIEF GEOLOGIST TO LEAD NEXT PHASE AT SKAERGAARD - PR Newswire
Buyback Watch: What is the earnings history of Klotho Neurosciences Inc Equity WarrantWeekly Trend Recap & Expert Verified Movement Alerts - baoquankhu1.vn
Buyout Rumor: Is Klotho Neurosciences Inc Equity Warrant forming a double bottom2026 Bull vs Bear & Proven Capital Preservation Methods - baoquankhu1.vn
Greenland Mines Joins Business Association to Enhance Local Engagement - Intellectia AI
Zacks.com - Zacks Investment Research
Greenland Mines Subsidiary Major Precious Greenland A/S Joins Greenland Business Association - PR Newswire
GRML: Klotho Neurosciences, Inc.Brokerage Recommendations Chart - Zacks Investment Research
Klotho Neurosciences acquires Greenland palladium-gold project By Investing.com - Investing.com UK
Greenland Mines joins Greenland business network through local subsidiary - Stock Titan
Whale Trades: Can Klotho Neurosciences Inc grow without external fundingChart Signals & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Greenland Mines Ltd (Formerly Klotho Neurosciences, Inc.) – Gene Therapy, Biosimilars, and Regulatory Strategy for Neurologic and Chronic Diseases - Minichart
[10-K] Greenland Mines Ltd Files Annual Report - Stock Titan
Greenland Mines 10-K: $0 Revenue, Net Loss $10.55M, Cash $7.18M - TradingView
Greenland Mines Ltd Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Greenland Mines Delays Annual 10-K Filing - TipRanks
Greenland Mines Ltd (GRML) files Form 12b-25 for late 10-K filing - Stock Titan
Growth Recap: Is Klotho Neurosciences Inc Equity Warrant part of any major index2026 Trade Ideas & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Dow Update: How much upside does Klotho Neurosciences Inc Equity Warrant have2026 Big Picture & Capital Protection Trade Alerts - baoquankhu1.vn
Klotho Neurosciences expands into mining with Greenland mines deal - MSN
Klotho Neurosciences advances epigenetic diagnostics with development of AI-driven "Klotho Clock" - MSN
Greenland Mines receives additional 180-day Nasdaq compliance period - MSN
Greenland Mines locks in rare icebreaker as 2026 Arctic base - Stock Titan
Nasdaq grants Greenland Mines (GRML) 180-day extension to regain $1 bid price compliance - Stock Titan
Greenland Mines Secures Additional 180-Day Period for Nasdaq Bid Price Compliance - Lelezard
Greenland Mines secures additional 180-day period for Nasdaq bid price compliance - marketscreener.com
Greenland Mines gets 180-day extension for Nasdaq compliance By Investing.com - Investing.com UK
What is the current Price Target and Forecast for Klotho Neurosciences, Inc. (GRML) - Zacks Investment Research
Greenland Mines Engages WSP Denmark to Launch Comprehensive Environmental Baseline Program at Skaergaard Mining Site - mycarrollcountynews.com
Two-year Arctic survey starts as Greenland mine pursues permit - Stock Titan
Klotho Neurosciences Stock Jumps As FDA Grants Orphan Drug Tag To ALS Gene Therapy - MSN
Short Covering: What are Klotho Neurosciences Inc Equity Warrants growth levers2026 Year in Review & Growth Focused Entry Reports - baoquankhu1.vn
Winners Losers: Is Klotho Neurosciences Inc likely to announce a buybackCEO Change & AI Driven Stock Price Forecasts - baoquankhu1.vn
GRML : Klotho Neurosciences, Inc. Key Company Details - zacks.com
GRML : Klotho Neurosciences, Inc. Key Company Metrics & Non-finance Metrics - Zacks Investment Research
Greenland Mines Rebrands and Launches Dual-Focus Strategy - TipRanks
Greenland Mines Ltd (Nasdaq: GRML) rebrands and outlines dual divisions - Stock Titan
Klotho Neurosciences, Inc. (GRML) Debt Equity Ratio (Quarterly) - Zacks Investment Research
All News for GRML : Klotho Neurosciences, Inc. - Zacks Investment Research
Klotho Neurosciences, Inc. (GRML) Total Expenses (Quarterly) - Zacks Investment Research
Klotho Neurosciences, Inc. (GRML) Total Liabilities - Zacks Investment Research
Klotho Neurosciences, Inc. (GRML) Book Value - Zacks Investment Research
Klotho Neurosciences, Inc. (GRML) Cash From Operations (TTM) - Zacks Investment Research
Klotho Neurosciences, Inc. (GRML) Return On Equity (TTM) - Zacks Investment Research
Klotho Neurosciences, Inc. (GRML) Gross Margin (TTM) - Zacks Investment Research
Klotho Neurosciences, Inc. (GRML) Shareholders Equity (Quarterly) - Zacks Investment Research
Klotho Neurosciences, Inc. (GRML) Profit Margin (Quarterly) - Zacks Investment Research
Finanzdaten der Klotho Neurosciences Inc-Aktie (KLTO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):